Geode Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54.6K | Sell |
|
|||||
2025
Q1 | $54.5K | Hold |
|
|||||
2024
Q4 | $61.6K | Hold |
|
|||||
2024
Q3 | $62.1K | Hold |
|
|||||
2024
Q2 | $65.4K | Hold |
|
|||||
2024
Q1 | $74.3K | Hold |
|
|||||
2023
Q4 | $58.8K | Buy |
|
|||||
2023
Q3 | $54.6K | Hold |
|
|||||
2023
Q2 | $74.9K | Buy |
|
|||||
2023
Q1 | $39.5K | Hold |
|
|||||
2022
Q4 | $218K | Hold |
|
|||||
2022
Q3 | $117K | Hold |
|
|||||
2022
Q2 | $83K | Sell |
|
|||||
2022
Q1 | $2.78M | Buy |
|
|||||
2021
Q4 | $3.5M | Sell |
|
|||||
2021
Q3 | $5.43M | Buy |
|
|||||
2021
Q2 | $2.91M | Buy |
|
|||||
2021
Q1 | $172K | Hold |
|
|||||
2020
Q4 | $71K | Hold |
|
|||||
2020
Q3 | $44K | Hold |
|
|||||
2020
Q2 | $59K | Hold |
|
|||||
2020
Q1 | $51K | Hold |
|
|||||
2019
Q4 | $87K | Hold |
|
|||||
2019
Q3 | $54K | Hold |
|
|||||
2019
Q2 | $60K | Buy |
|